invoX Pharma Limited.
invoX Pharma Limited (invoX), with headquarters based in London, is a wholly-owned subsidiary of Sino Biopharmaceutical Limited (Sino Biopharm). Our goal is to be a fully integrated biopharmaceutical company with an advancing pipeline of innovative products addressing unmet healthcare needs. We have several leading technology platform, amongst which includes Softhale, a next generation soft-mist inhalation delivery platform.
We are also the largest owner of Karolinska Development AB, a Swedish innovative development company, and founded by Karolinska Institute Holding AB, one of the Europe’s largest medical universities and Sweden’s largest centrefor medical training and research.